date:May 18, 2022
The research, development and improvement company Inveseed, technological partner of the Intersemillas group, has been authorized by the Spanish Agency of Medicines and Health Products (AEMPS) to carry out research on medical cannabis. The firm is being advised by the company CBD Therapy S.L. The main objective of the project is the creation of varieties with a high content of medicinal cannabinoids, specifically cannabidiol (CBD).
Scientific studies show that cannabidiol (CBD) is a cannabinoi